RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation.
Bird
Gregory
G
Department of Biochemistry and Molecular Genetics, University of Colorado Health Science Center at Fitzsimons, P.O. Box 6511, Aurora, CO 80045, USA.
Zorio
Diego A R
DA
Bentley
David L
DL
D000546:Amanitins / Q000378:metabolism; D000818:Animals; D004004:Dichlororibofuranosylbenzimidazole / Q000378:metabolism; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism; D019384:Nucleic Acid Synthesis Inhibitors / Q000378:metabolism; D009865:Oocytes / Q000502:physiology; D010766:Phosphorylation; D017434:Protein Structure, Tertiary; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012322:RNA Precursors / Q000378:metabolism*; D012323:RNA Processing, Post-Transcriptional; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D014982:Xenopus laevis
D000546:Amanitins; D007546:Isoquinolines; D019384:Nucleic Acid Synthesis Inhibitors; D012322:RNA Precursors; D012333:RNA, Messenger; D004004:Dichlororibofuranosylbenzimidazole; C053177:N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide; D012319:RNA Polymerase II